Thus, this methyl-arginine profiling effort of digenic PD mouse models identifies dysregulations of CRTC1 as a potential key factor, where the effects of alpha-Synuclein on synaptic plasticity converge with the effects of PINK1 on mitochondrial quality control. This evidence concerns the gene SNCA and Parkinson disease.